FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

982801000168105: Ibrance (palbociclib 75 mg) capsule (trade product unit of use)


Status: current, Defined. Date: 31-Aug 2017. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
2530011000168117 Ibrance (palbociclib 75 mg) capsule (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
2530021000168112 Ibrance 75 mg capsule en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ibrance 75 mg capsule has manufactured dose form capsule true Inferred relationship Some
Ibrance 75 mg capsule Is a trade product unit of use true Inferred relationship Some
Ibrance 75 mg capsule Is a Ibrance true Inferred relationship Some
Ibrance 75 mg capsule Is a palbociclib 75 mg capsule true Inferred relationship Some
Ibrance 75 mg capsule has manufactured dose form hard capsule false Inferred relationship Some
Ibrance 75 mg capsule has unit of use capsule true Inferred relationship Some 903755963
Ibrance 75 mg capsule has Australian BoSS palbociclib true Inferred relationship Some 903755962
Ibrance 75 mg capsule has intended active ingredient palbociclib true Inferred relationship Some 903755962

Inbound Relationships Type Active Source Characteristic Refinability Group
Ibrance (palbociclib 75 mg) capsule, 21 capsules, bottle (containered trade product pack) has TPUU True Ibrance 75 mg capsule Inferred relationship Some 1
Ibrance 75 mg capsule, 21, blister pack has TPUU True Ibrance 75 mg capsule Inferred relationship Some 1
Ibrance 75 mg capsule, 21 has TPUU True Ibrance 75 mg capsule Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start